These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 18701818

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determinants of circulating matrix metalloproteinase-2 and pregnancy-associated plasma protein-A in patients with chronic kidney disease.
    Zakiyanov O, Kalousová M, Kratochvilová M, Kríha V, Zima T, Tesar V.
    Clin Lab; 2012; 58(5-6):471-80. PubMed ID: 22783577
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?
    Peiskerová M, Kalousová M, Kratochvílová M, Dusilová-Sulková S, Uhrová J, Bandúr S, Malbohan IM, Zima T, Tesar V.
    Kidney Blood Press Res; 2009; 32(4):276-83. PubMed ID: 19797911
    [Abstract] [Full Text] [Related]

  • 13. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 14. Association between elevated visfatin and carotid atherosclerosis in patients with chronic kidney disease.
    Tang X, Chen M, Zhang W.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jun 20; 38(6):553-9. PubMed ID: 23828708
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease.
    Bao YS, Na SP, Jia XB, Liu RC, Wang MA, Yu CY, Mu SH, Xie RJ.
    Curr Med Res Opin; 2012 Mar 20; 28(3):379-84. PubMed ID: 22335251
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Negative association between serum levels of matrix metalloproteinases-2 and -9 and aortic stiffness in healthy adults.
    Vlachopoulos C, Aznaouridis K, Dima I, Ioakeimidis N, Vasiliadou C, Zervoudaki A, Gialernios T, Stefanadis C.
    Int J Cardiol; 2007 Nov 30; 122(3):232-8. PubMed ID: 17289174
    [Abstract] [Full Text] [Related]

  • 20. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.
    Sapienza P, di Marzo L, Borrelli V, Sterpetti AV, Mingoli A, Piagnerelli R, Cavallaro A.
    Eur J Vasc Endovasc Surg; 2004 Jul 30; 28(1):89-97. PubMed ID: 15177237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.